The MOGE(S) classification for cardiomyopathies: current status and future outlook

@article{Westphal2017TheMC,
  title={The MOGE(S) classification for cardiomyopathies: current status and future outlook},
  author={J. Westphal and A. Rigopoulos and C. Bakogiannis and Sarah Ludwig and S. Mavrogeni and B. Bigalke and T. Doenst and M. Pauschinger and C. Tschoepe and P. Schulze and M. Noutsias},
  journal={Heart Failure Reviews},
  year={2017},
  volume={22},
  pages={743-752}
}
  • J. Westphal, A. Rigopoulos, +8 authors M. Noutsias
  • Published 2017
  • Medicine
  • Heart Failure Reviews
  • Cardiomyopathies are complex diseases of multifactorial pathogenesis and have a high morbidity and mortality. Over the past decades, several revisions of classifications and definitions of cardiomyopathies have been proposed, primarily focusing on the phenotypic characterization of cardiomyopathies. The MOGE(S) classification system published in 2013 encompasses the classification of rapidly growing knowledge on genetic mutations, acquired causes (i.e., intramyocardial inflammation, viral… CONTINUE READING
    32 Citations
    Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment
    • 10
    Clinicopathological manifestations of myocarditis in a heart failure population.
    • L. M. Buja, G. Ottaviani, +12 authors B. Kar
    • Medicine
    • Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
    • 2019
    • 2
    Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement
    • 6
    Advancements in the diagnostic workup, prognostic evaluation, and treatment of takotsubo syndrome
    • 8
    Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy
    • 12
    Updates on the Genetic Paradigm in Heart Failure
    • 1

    References

    SHOWING 1-10 OF 63 REFERENCES
    The MOGE(S) classification of cardiomyopathy for clinicians.
    • 113
    Clinical application of WHF-MOGE(S) classification for hypertrophic cardiomyopathy.
    • 9
    The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation.
    • 116
    • PDF
    Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy: Applying the MOGE(S) Classification.
    • 47
    Cardiomyopathies: MOGE(S): a standardized classification of cardiomyopathies?
    • B. Mayosi
    • Medicine
    • Nature Reviews Cardiology
    • 2014
    • 7
    • PDF
    The cardiomyopathies.
    • 28
    • Highly Influential
    • PDF
    Epidemiologie –Ätiologie der dilatativen Kardiomyopathie
    • H. Olbrich
    • Medicine
    • Zeitschrift für Kardiologie
    • 2001
    • 24
    Giant cell myocarditis: still a conundrum. The need for a worldwide registry
    • 8